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Diuron (3-(3,4-dichlorophenyl)-I,l-dimethylurea) and antimycin, both inhibitors of mitochondrial respiration, block 
electron flow between cytochromes b and c,. Mutants resistant o either drug have been selected using Schizosacchuromy- 
ces pombe strains with an extrachromosomally inherited mutator. In analogy to Sacchoromyces cerevisiae these mutatio- 
nal sites were assumed to map in the cytochrome b gene. DNA sequence analysis showed that two changes in the same 
nucleotide are responsible for resistance to antimycin and diuron. Analysis of resistant and sensitive progeny of crosses 
between the mutants and the wild type confirmed the correlation between mutational alteration and resistant phenotype. 
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1. INTRODUCTION 
After treatment with N’-nitro-N-nitroso- 
guanidine several mitochondrial mutants have been 
isolated in the fission yeast Schizosaccharomyces 
pombe strain ade7-50h- (strain 50 for short), 
which are resistant o antimycin both in vivo and in 
vitro [1,2]. Concomitantly, a mutator mutation 
was induced in all of them. This mutator causes an 
increased susceptibility of the mitochondrial 
genome towards point mutations and deletions of 
the mitochondrial DNA [3-51. In analogy to Sac- 
charomyces cerevisiae, the antimycin resistant 
mutants have been allocated to the cytochrome b 
gene [a]. In SC. pombe, the cytochrome b gene 
(cob) is split by a group II intron 171. In order to 
facilitate sequencing of drug-resistant mutants in 
the cob gene, we have constructed an intronless cob 
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gene by intron DNA splicing [8]. In this strain we 
have selected mutants resistant o diuron (3-(3,4-di- 
chlorophenyl)1,1-dimethylurea), which is also an 
inhibitor of the respiratory chain between cyto- 
chromes b and cl [9]. In this paper we describe the 
base changes leading to diuron- and antimycin- 
resistance and discuss the results in relation to 
previous genetic data from mutant selection and 
from crosses between resistant mutants [lo]. The 
mutational alterations will also be discussed con- 
cerning a modification of the current model for 
protein folding of the cytochrome b apoprotein 
ill]. 
2. MATERIALS AND METHODS 
2.1. Strains and plosmid 
The SC. pombe mutant ude7-5Oh- was from the collection of 
U. Leupold, Berne. The meiosis deficient strain meil ode6 was 
kindly provided by R. Egel, Copenhagen. The diuron resistant 
strain diu’-301 is described in [12]. The mutant strains and-X39 
and ana’X39 are described in this paper. The E. coti strain JM 
101 lac- , pro-, amp’, F+, pro’ was used for cloning. Plasmid 
pFikl71 is described in [13]. 
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2.2. Genetic techniques 
Media, selection of mutants, construction of stable diploids, 
mitotic segregation analysis, random spore analysis and meiotic 
crosses are described in [2]. 
2.3. Molecular techniques 
For preparation of mitochondrial DNA, restriction enzyme 
digestion, agarose gel electrophoresis, electroelution, nick- 
translation, Southern hybridization, Ml3 cloning and DNA se- 
quencing according to Sanger, standard procedures were used; 
relevant modifications of these techniques are given in [13]. 
Hydrophobicity patterns were evaluated according to 1141 and 
protein secondary structures determined according to [ 151 using 
an IBM-AT computer. 
3. RESULTS AND DISCUSSION 
3.1. The diuron-resistant mutant diu’-301 
The nucleotide sequence of the entire cob gene 
has been determined for strain ade7-50h- (referred 
to as the mitochondrial wild-type), from which the 
antimycin-resistant mutant and-24 has been de- 
rived by nitrosoguanidine mutagenesis [ 121. 
Diu’3OZ is a spontaneous mutant of and-14 which 
has lost antimycin resistance - a phenomenon 
which will be discussed later. The two exonic 
regions of the cob gene have been sequenced and 
compared with the homologous sequences in the 
wild type. In mutant diu’-3OZ the C in position 110 
(position 1 is the A of the ATG initiation codon) is 
changed into G. This base change leads to the 
replacement of an alanine (Ala) by glycine (Gly) in 
position 37. 
In order to correlate the mutational change with 
the resistance phenotype, mutant diu’-301 was 
crossed with the meiosis deficient strain meil leu2. 
The diploid progeny showed mitotic segregation of 
resistance versus sensitivity to diuron (not shown) 
thus indicating extrachromosomal inheritance. 
Resistant diploids were purified three times on 
diuron medium and sensitive diploids were checked 
by replica plating on drug medium. Cloning and se- 
quencing of the relevant part of the cob gene 
revealed that the C to G transversion is only found 
in the resistant clones. 
3.2. The antimycin-resistant mutant ana’-X39 
In order to facilitate cloning and sequencing of 
the cob gene, a derivative of mutant and-14, mu- 
tant ana’-X39, was used in which the cob intron has 
been removed by intron DNA splicing [8]. After se- 
quencing the cob gene only one base change was 
32 
discovered, concerning the same nucleotide as in 
the diuron-resistant mutant: in this case the C was 
replaced by a T. This transition leads to the 
replacement of alanine (Ala) by valine (Val). 
Analysis of diploids issued from mitotic segrega- 
tion (see above) confirmed that the C to T transi- 
tion is correlated with the antimycin resistance (not 
shown). 
3.3. Origin and allelism of drug-resistant mutants 
in the cob gene 
A series of diuron-resistant mutants has been 
isolated in ana’-Z4, which could be classified in 3 
types. Type I isolates (60%) could grow on both 
drug media (antimycin and diuron), type II isolates 
(35%) were initially able to grow on both drug 
media, but not on the double medium. These 
mutants very likely contained mixtures of two dif- 
ferent mitochondrial genomes. Type III isolates 
(5%), like mutant diu’-3OZ, have lost the capacity 
to grow on antimycin medium [12]. Analysis of 
6040 spores from a cross between diu’-301 and 
and-Z4 did not yield any double resistant recombi- 
nant. Both observations can now be explained by 
the fact, that the same nucleotide has mutated in 
the two resistant strains. 
3.4. Consequences of the amino acid changes in 
the cytochrome b protein 
The changes from Ala (position 37) to Gly in 
diu’-301 and from Ala to Val in ana’-X29 slightly 
changes the hydrophobicity of the transmembrane 
segment I (fig.1). Alanine carries an uncharged R 
group (CH3), and the additional methyl group of V 
slightly increases hydrophobicity. Gly (in mutant 
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Fig. 1. Revised model for folding of apocytochrome baccording 
to [I 11. The filled circles are the four invariant histidine residues 
which bind the two heme groups. The numbers refer to the 
amino acid changes listed in table 2. 
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Table 1 Table 3 
Protein secondary structure in the antimycin domain 
Strain Amino acid sequence Conformation 
37 37 
* * 
ade7-SOh- FWNFGSLLACVLVIQ EEETTTCHHHEEEEE 
diu’-301 ********G****** EEETTTCTTEEEEEE 
and-X39 ********V****** EETTTTCEEEEEEEE 
Comparison of the amino acid sequences of the antimycin 
domain from different organisms 
Organisms Antimycin domain 
37 
* 
The protein secondary structure was determined according to 
[14]. H = cu-helical, E = p-sheet, T = a-turn, C = no ordered 
Schizosaccharomyces 
Aspergillus 
Neurospora 
Rhodobacter 
FWNFGSLLACVLVIQ 
LWNFGSLLALCLGIP 
LWNFGSLLACCLIIP 
WWIWGSLLAFTLVLQ 
configuration 
a&-X39) leads to a decrease in hydrophobicity 
due to its polar and neutral properties. It is unlikely 
that local changes in the hydrophobicity profile are 
responsible for differential drug binding. It is more 
likely that alterations in the secondary structure of 
the first transmembrane segment play a role in in- 
hibitor binding. The local protein secondary struc- 
ture was determined according to [14] and the 
results are summarized in table 1. In the wild type 
(strain 50) the Ala in position 37, together with the 
surrounding amino acids, form a short a-helical 
segment. The amino acid changes in both resistant 
mutants lead to destruction of this helical segment, 
as indicated in table 1. These conformational 
changes very likely influence the differential bind- 
ing of the drugs in wild type and mutants. 
Sacchardmyces 
Drosophila 
Xenopus 
Mouse 
Bovine 
Human 
Maize 
Wheat 
Trypanosoma 
WWNMGSLLGLCLVIQ 
WWNFGSLLGLCLIIQ 
LWNFGSLLGVCLIAQ 
WWNFGSLLGVCLNVQ 
WWNFGSLLGICLILQ 
WWNFGSLLGACLILQ 
WWGFGCLAGICLVIQ 
WWGFGSLAGICLVIQ 
IYGVGFSLGFFIALQ 
Spinach chloroplast be FYCLGGITLTCFLVQ 
Tobacco chloroplast b6 FYCLGGITLTCFLVQ 
Liverwort chloroplast be FYCLGGITLTCFLVQ 
The sequences are aligned relative to the SC. pombe sequence. 
Taken from [11], where all references can be found 
3.5. Segment I is part of the antimycin-binding 
domain 
Table 2 summarizes the published sequence data 
of various drug-resistant mutants in mouse, S. 
cerevisiae and SC. pombe mitochondria. It is in- 
teresting to note that four different mutational 
sites concern the amino acid position 37. A com- 
parison of this segment from various organisms 
(table 3) reveals that SC. pombe, Aspergillus 
nidulans, Neurospora crassa and Rhodobacter 
possess an Ala at this position, whereas the majori- 
ty of organisms (including S. cerevisiae) has a Gly. 
It is tempting to speculate that the Ala in position 
Number 
Table 2 
Compilation of amino acid changes in inhibitor-resistant mutants 
Amino acid Organism Resistance Amino acid 
position towards change 
Reference 
1 17 S. cerevisiae diuron I -‘F 1181 
2 31 S. cerevisiae diuron N-+K ttsl 
3 37 mouse antimycin G-V 1111 
3 37 S. cerevisiae antimycin G+V ]llla 
3 37 SC. pombe antimycin A-+V this work 
3 37 SC. pombe diuron A-G this work 
4 141 mouse myxothiazol G-A 1181 
5 225 S. cerevisiae diuron F+S WI 
6 230 mouse HQNO G-D 11’31 
a Colson, A.-M., personal communication, quoted in [11] 
Amino acid positions are according to SC. pombe. The numbers refer to the locations of amino acid changes in 
fig.1 
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37 might correlate with the much higher resistance 
in vivo and in vitro of antimycin-resistant mutants 
of SC. pombe compared to those of S. cerevisiae. In 
the chloroplast cytochrome be proteins, there is a 
leucine residue at the homologous position which 
might be responsible for the lOOO-fold higher 
resistance to antimycin compared with mitochon- 
dria. In this context it should be mentioned that it 
has been described in a previous paper [ 121 that the 
antimycin-resistant mutant and-14 is more sen- 
sitive to diuron than the corresponding wild type. 
Only half of the amount of diuron is needed in the 
mutant to reduce the growth rate to 50%. It could 
be assumed that the change from Ala to Val 
simultaneously increases resistance towards anti- 
mycin and decreases the tolerance to diuron. 
3.6. The revised model of the folding of 
apocytochrome b
The basic features of the models of Widger et al. 
[16] and Saraste [17] are the nine hydrophobic do- 
mains spanning the inner mitochondrial mem- 
brane. Analysis of drug-resistance mutations has 
led to serious inconsistencies in regard to their loca- 
tion on both sides of the membrane and in relation 
to the heme group [l 11. Howell and Gilbert [ 111 
therefore suggested a modification of Widger- 
Saraste model is depicted in and 
discussed in in [ 111. The basic differences 
between old and the revised model are (i) the in- 
verse orientation of amino-terminus and conse- 
of segments I-III in membrane, and 
IV located outside the membrane. 
Fitting all available on mutants, including 
those in this paper, in the revised model, 
it appears the amino of all 
mutants resistant to drugs 
and HQNO) are located at the 
inside, whereas target for myxothiazol is the 
outside of inner membrane. 
Concluding remarks 
Mitochondrial mutants conferring to drugs in- 
hibiting the electron transport provide an excellent 
tool to elucidate the architecture of membrane 
bound enzyme complexes. The molecular analysis 
of all available drug-resistant mutants in the cyto- 
chrome b gene will certainly deepen our under- 
standing of the structure and function of the 
respiratory chain. 
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